Stepan Reports Second Quarter 2025 Results
Second Quarter 2025 Highlights
- Reported net income was
$11.3 million , up 19% versus the prior year. Adjusted net income(1) was$12.0 million , up 27% versus the prior year, driven by earnings growth within Polymers, our Crop Productivity business and a lower effective tax rate. - EBITDA(2) was
$50.6 million and Adjusted EBITDA(2) was$51.4 million , up 6% and 8% respectively, year-over-year. - Global sales volume was up 1% year-over-year.
- Cash from Operations was
$11.2 million during the quarter. Free cash flow(3) for the quarter was a negative$14.4 million , primarily due to increased working capital needs to support business growth, build inventory ahead of anticipated tariffs, and maintain safety stock in preparation for the hurricane season and a new collective bargaining agreement at our Millsdale site. - Pre-tax earnings were negatively impacted by
$6.1 million primarily due to start-up costs associated with our new alkoxylation site inPasadena, Texas , and an environmental remediation reserve adjustment at our Millsdale site.
First Half 2025 Highlights
- Reported net income was
$31.1 million , up 33% versus the prior year. Adjusted net income(1) was$31.3 million , up 30% versus the prior year. - EBITDA(2) was
$108.6 million and Adjusted EBITDA(2) was$108.9 million , up 11% and 10% respectively, year-over-year. - Global sales volume was up 2% year-over-year.
"Quarterly earnings were up double digits driven by improved Polymer and Crop Productivity results as well as a lower effective tax rate. Polymer volume was up 7% as the North American Rigid, European Rigid and Phthalic Anhydride businesses all delivered volume growth. Within Surfactants, we also continued to experience double digit volume growth within the Agricultural and Oilfield end markets. This growth was offset by lower demand within the global commodity Consumer Products end markets," said
Financial Summary
|
Three Months Ended |
Six Months Ended |
|||||||||||||||||||||||
|
($ in thousands, except per share data) |
2025 |
2024 |
% |
2025 |
2024 |
% |
||||||||||||||||||
|
|
$ |
594,689 |
$ |
556,405 |
7 |
% |
$ |
1,187,944 |
$ |
1,107,823 |
7 |
% |
||||||||||||
|
Operating Income |
$ |
17,965 |
$ |
18,667 |
(4) |
% |
$ |
46,253 |
$ |
38,836 |
19 |
% |
||||||||||||
|
Net Income |
$ |
11,341 |
$ |
9,521 |
19 |
% |
$ |
31,052 |
$ |
23,414 |
33 |
% |
||||||||||||
|
Earnings per Diluted Share |
$ |
0.50 |
$ |
0.42 |
19 |
% |
$ |
1.36 |
$ |
1.02 |
33 |
% |
||||||||||||
|
Adjusted Net Income * |
$ |
11,952 |
$ |
9,396 |
27 |
% |
$ |
31,262 |
$ |
24,052 |
30 |
% |
||||||||||||
|
Adjusted Earnings per |
$ |
0.52 |
$ |
0.41 |
27 |
% |
$ |
1.37 |
$ |
1.05 |
30 |
% |
||||||||||||
|
* See Table II for reconciliations of non-GAAP adjusted net income and adjusted earnings per diluted share. |
Percentage Change in
Net sales in the second quarter of 2025 increased 7% year-over-year. This increase was primarily driven by higher selling prices that were mainly attributable to the pass-through of higher raw material costs and more favorable product mix.
|
Three Months Ended |
Six Months Ended |
|||||||
|
Volume |
1 |
% |
2 |
% |
||||
|
Selling Price & Mix |
6 |
% |
7 |
% |
||||
|
Foreign Translation |
(—) |
% |
(2) |
% |
||||
|
Total |
7 |
% |
7 |
% |
||||
Segment Results
|
Three Months Ended |
Six Months Ended |
|||||||||||||||||||||||
|
($ in thousands) |
2025 |
2024 |
% |
2025 |
2024 |
% |
||||||||||||||||||
|
|
||||||||||||||||||||||||
|
Surfactants |
$ |
411,456 |
$ |
379,795 |
8 |
% |
$ |
841,793 |
$ |
770,615 |
9 |
% |
||||||||||||
|
Polymers |
$ |
162,751 |
$ |
159,757 |
2 |
% |
$ |
308,867 |
$ |
305,265 |
1 |
% |
||||||||||||
|
Specialty Products |
$ |
20,482 |
$ |
16,853 |
22 |
% |
$ |
37,284 |
$ |
31,943 |
17 |
% |
||||||||||||
|
Total |
$ |
594,689 |
$ |
556,405 |
7 |
% |
$ |
1,187,944 |
$ |
1,107,823 |
7 |
% |
||||||||||||
|
Three Months Ended |
Six Months Ended |
|||||||||||||||||||||||
|
($ in thousands, all amounts pre-tax) |
2025 |
2024 |
% |
2025 |
2024 |
% |
||||||||||||||||||
|
Operating Income |
||||||||||||||||||||||||
|
Surfactants |
$ |
13,367 |
$ |
17,062 |
(22) |
% |
$ |
42,297 |
$ |
43,142 |
(2) |
% |
||||||||||||
|
Polymers |
$ |
17,159 |
$ |
13,597 |
26 |
% |
$ |
25,177 |
$ |
21,979 |
15 |
% |
||||||||||||
|
Specialty Products |
$ |
5,258 |
$ |
7,319 |
(28) |
% |
$ |
10,766 |
$ |
11,587 |
(7) |
% |
||||||||||||
|
Total Segment |
$ |
35,784 |
$ |
37,978 |
(6) |
% |
$ |
78,240 |
$ |
76,708 |
2 |
% |
||||||||||||
|
Corporate Expenses |
$ |
(17,819) |
$ |
(19,311) |
(8) |
% |
$ |
(31,987) |
$ |
(37,872) |
(16) |
% |
||||||||||||
|
Consolidated |
$ |
17,965 |
$ |
18,667 |
(4) |
% |
$ |
46,253 |
$ |
38,836 |
19 |
% |
||||||||||||
|
Three Months Ended |
Six Months Ended |
|||||||||||||||||||||||
|
($ in millions) |
2025 |
2024 |
% |
2025 |
2024 |
% |
||||||||||||||||||
|
EBITDA |
$ |
50.6 |
$ |
47.9 |
6 |
% |
$ |
108.6 |
$ |
98.0 |
11 |
% |
||||||||||||
|
Adjusted EBITDA |
||||||||||||||||||||||||
|
Surfactants |
$ |
34.5 |
$ |
35.0 |
(1) |
% |
$ |
82.9 |
$ |
78.6 |
5 |
% |
||||||||||||
|
Polymers |
$ |
25.6 |
$ |
21.8 |
17 |
% |
$ |
41.6 |
$ |
38.2 |
9 |
% |
||||||||||||
|
Specialty Products |
$ |
6.7 |
$ |
8.8 |
(24) |
% |
$ |
13.7 |
$ |
14.6 |
(6) |
% |
||||||||||||
|
Unallocated Corporate |
$ |
(15.4) |
$ |
(17.9) |
(14) |
% |
$ |
(29.3) |
$ |
(32.5) |
(10) |
% |
||||||||||||
|
Consolidated Adjusted EBITDA |
$ |
51.4 |
$ |
47.7 |
8 |
% |
$ |
108.9 |
$ |
98.9 |
10 |
% |
||||||||||||
Consolidated adjusted EBITDA(2) increased
- Surfactant net sales were
$411.5 million for the quarter, an 8% increase versus the prior year. Selling prices were up 11% primarily due to improved product and customer mix and the pass through of higher raw material costs. Sales volume declined 1% year-over-year primarily due to lower demand within the commodity Laundry and Cleaning end markets that was largely offset by double digit growth within the Agricultural and Oilfield end markets. Foreign currency translation negatively impacted net sales by 2%. Surfactant adjusted EBITDA(2) for the quarter decreased$0.5 million , or 1%, versus the prior year. This decrease was primarily due to higher expenses associated with the start-up of our new alkoxylation facility inPasadena, Texas , a Millsdale-related remediation reserve adjustment and an EPA penalty recognized in the second quarter of 2025. Excluding these items, adjusted EBITDA was up double digits. Current year adjusted EBITDA was also negatively impacted by higher Oleochemical raw material costs that we intend to recover via pricing in the second half of the year. - Polymer net sales were
$162.8 million for the quarter, a 2% increase versus the prior year. Selling prices decreased 7%, primarily due to the pass-through of lower raw material costs and competitive pressures. Sales volume increased 7% in the quarter. North American Rigid, European Rigid and commodity Phthalic Anhydride sales volume was up year-over-year. Foreign currency translation positively impacted net sales by 2% during the quarter. Polymer adjusted EBITDA(2) increased$3.8 million , or 17%, versus the prior year primarily due to the 7% sales volume growth. - Specialty Product net sales were
$20.5 million for the quarter, a 22% increase versus the prior year, primarily due to higher sales volume. Specialty Product adjusted EBITDA(2) decreased$2.1 million , or 24%. The decrease in adjusted EBITDA(2) was primarily due to order timing fluctuations within the pharmaceutical business, as orders were moved from the second quarter to the second half of the year.
Income Taxes
The Company's effective tax rate was 19.2% in the first half of 2025 versus 36.1% in the first half of 2024. This decrease was primarily attributable to a favorable tax audit settlement in 2025 combined with the non-recurrence of an unfavorable GILTI-related event in the first half of 2024. These items were partially offset by the expected tax impact of certain cash repatriations to the United States.
Outlook
"Looking forward, we remain focused on accelerating our business strategies through enhanced operational excellence, improved product and customer mix and accelerated free cash flow generation. We believe our Surfactant business will experience continued growth in our key strategic end markets and that Polymer demand will continue improving as we get more market certainty and we execute our innovation and growth plans. Our Pasadena facility is now operational, and as we have previously communicated, this will enable us to deliver volume growth in our alkoxylation product line and Supply Chain savings during the second half of the year," said
Notes
(1) Adjusted net income and adjusted earnings per share are non-GAAP measures which exclude deferred compensation income/expense, certain environmental remediation-related costs as well as other significant and infrequent/non-recurring items. See Table II for reconciliations of non-GAAP adjusted net income and adjusted earnings per diluted share.
(2) EBITDA and adjusted EBITDA are non-GAAP measures. See Table VI for calculations and GAAP reconciliations of EBITDA and adjusted EBITDA.
(3) Free cash flow is a non-GAAP measure and reflects cash generated from operations minus capital expenditures. Cash generated from operations was
Conference Call
Supporting Slides
Slides supporting this press release will be made available at www.stepan.com through the Investors/Presentations page at approximately the same time as this press release is issued.
Corporate Profile
Headquartered in
The Company's common stock is traded on the
More information about Stepan's sustainability program can be found on the Sustainability page at www.stepan.com
Certain information in this news release consists of forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995, Section 27A of the Securities Act of 1933, as amended, and Section 21E of the Securities Exchange Act of 1934, as amended. These statements include statements about
There are a number of risks, uncertainties and other important factors, many of which are beyond
These forward-looking statements are made only as of the date hereof, and
* * * * *
Tables follow
|
Table I |
||||||||||||||||
|
|
||||||||||||||||
|
For the Three and Six Months Ended |
||||||||||||||||
|
(Unaudited – in 000's, except per share data) |
||||||||||||||||
|
Three Months Ended |
Six Months Ended |
|||||||||||||||
|
2025 |
2024 |
2025 |
2024 |
|||||||||||||
|
|
$ |
594,689 |
$ |
556,405 |
$ |
1,187,944 |
$ |
1,107,823 |
||||||||
|
Cost of Sales |
522,804 |
486,853 |
1,040,596 |
967,990 |
||||||||||||
|
Gross Profit |
71,885 |
69,552 |
147,348 |
139,833 |
||||||||||||
|
Operating Expenses: |
||||||||||||||||
|
Selling |
14,657 |
11,828 |
26,765 |
23,216 |
||||||||||||
|
Administrative |
22,801 |
24,569 |
44,215 |
47,259 |
||||||||||||
|
Research, Development and Technical Services |
14,701 |
14,093 |
29,350 |
28,349 |
||||||||||||
|
Deferred Compensation Expense (Income) |
1,761 |
395 |
765 |
2,173 |
||||||||||||
|
53,920 |
50,885 |
101,095 |
100,997 |
|||||||||||||
|
Operating Income |
17,965 |
18,667 |
46,253 |
38,836 |
||||||||||||
|
Other Income (Expense): |
||||||||||||||||
|
Interest, Net |
(5,485) |
(2,661) |
(9,611) |
(5,732) |
||||||||||||
|
Other, Net |
1,306 |
1,200 |
1,808 |
3,562 |
||||||||||||
|
(4,179) |
(1,461) |
(7,803) |
(2,170) |
|||||||||||||
|
Income Before Provision for Income Taxes |
13,786 |
17,206 |
38,450 |
36,666 |
||||||||||||
|
Provision for Income Taxes |
2,445 |
7,685 |
7,398 |
13,252 |
||||||||||||
|
Net Income |
11,341 |
9,521 |
31,052 |
23,414 |
||||||||||||
|
Net Income Per Common Share |
||||||||||||||||
|
Basic |
$ |
0.50 |
$ |
0.42 |
$ |
1.36 |
$ |
1.03 |
||||||||
|
Diluted |
$ |
0.50 |
$ |
0.42 |
$ |
1.36 |
$ |
1.02 |
||||||||
|
Shares Used to Compute Net Income Per Common Share |
||||||||||||||||
|
Basic |
22,865 |
22,827 |
22,866 |
22,825 |
||||||||||||
|
Diluted |
22,879 |
22,936 |
22,885 |
22,942 |
||||||||||||
|
Table II |
||||||||||||||||||||||||||||||||
|
Reconciliation of Non-GAAP Net Income and Earnings per Diluted Share* |
||||||||||||||||||||||||||||||||
|
Three Months Ended |
Six Months Ended |
|||||||||||||||||||||||||||||||
|
($ in thousands, except per share amounts) |
2025 |
EPS |
2024 |
EPS |
2025 |
EPS |
2024 |
EPS |
||||||||||||||||||||||||
|
Net Income Reported |
$ |
11,341 |
$ |
0.50 |
$ |
9,521 |
$ |
0.42 |
$ |
31,052 |
$ |
1.36 |
$ |
23,414 |
$ |
1.02 |
||||||||||||||||
|
Deferred Compensation |
$ |
69 |
$ |
0.00 |
$ |
(305) |
$ |
(0.01) |
$ |
(401) |
$ |
(0.02) |
$ |
(693) |
$ |
(0.03) |
||||||||||||||||
|
Environmental Remediation |
$ |
542 |
$ |
0.02 |
$ |
180 |
$ |
- |
$ |
611 |
$ |
0.03 |
$ |
1,331 |
$ |
0.06 |
||||||||||||||||
|
Adjusted Net Income |
$ |
11,952 |
$ |
0.52 |
$ |
9,396 |
$ |
0.41 |
$ |
31,262 |
$ |
1.37 |
$ |
24,052 |
$ |
1.05 |
||||||||||||||||
* All amounts in this table are presented after-tax
The Company believes that certain non-GAAP measures, in conjunction with comparable GAAP measures, are useful for evaluating the Company's operating performance and financial condition. The Company uses this non-GAAP information as an indicator of business performance and evaluates management's effectiveness with specific reference to these indicators. Management believes that these non-GAAP financial measures provide useful supplemental information because they exclude non-operational items that affect comparability between years. These measures should be considered in addition to, not as substitutes for or superior to, measures of financial performance prepared in accordance with GAAP and may differ from similarly titled measures presented by other companies. The Company's Annual Report on Form 10-K for the year ended
Summary of Second Quarter 2025 Adjusted Net Income Items
Adjusted net income excludes non-operational deferred compensation income/expense, certain environmental remediation costs and other significant and infrequent or non-recurring items.
- Deferred Compensation: The second quarter of 2025 reported net income includes
$0.1 million of after-tax expense versus$0.3 million of after-tax income in the prior year. - Environmental Remediation: The second quarter of 2025 reported net income includes
$0.5 million of after-tax expense versus$0.2 million of after-tax expense in the prior year.
|
Table III |
||||||||||||||||||||||||||||||||
|
Reconciliation of Pre-Tax to After-Tax Adjustments |
||||||||||||||||||||||||||||||||
|
Management uses the non-GAAP adjusted net income metric to evaluate the Company's operating performance. Management excludes the items listed in the table below because they are non-operational items. The cumulative tax effect was calculated using the statutory tax rates for the jurisdictions in which the transactions occurred. |
||||||||||||||||||||||||||||||||
|
Three Months Ended |
Six Months Ended |
|||||||||||||||||||||||||||||||
|
($ in thousands, except per share amounts) |
2025 |
EPS |
2024 |
EPS |
2025 |
EPS |
2024 |
EPS |
||||||||||||||||||||||||
|
Pre-Tax Adjustments |
||||||||||||||||||||||||||||||||
|
Deferred Compensation (Income) Expense |
$ |
92 |
$ |
(407) |
$ |
(534) |
$ |
(924) |
||||||||||||||||||||||||
|
Environmental Remediation Expense |
$ |
722 |
$ |
240 |
$ |
814 |
$ |
1,774 |
||||||||||||||||||||||||
|
Total Pre-Tax Adjustments |
$ |
814 |
$ |
(167) |
$ |
280 |
$ |
850 |
||||||||||||||||||||||||
|
Cumulative Tax Effect on Adjustments |
$ |
(203) |
$ |
42 |
$ |
(70) |
$ |
(212) |
||||||||||||||||||||||||
|
After-Tax Adjustments |
$ |
611 |
$ |
0.02 |
$ |
(125) |
$ |
(0.01) |
$ |
210 |
$ |
0.01 |
$ |
638 |
$ |
0.03 |
||||||||||||||||
|
Table IV |
||||||||||||||||||||||||
|
Deferred Compensation Plans |
||||||||||||||||||||||||
|
The full effect of the deferred compensation plans on quarterly pre-tax income was |
||||||||||||||||||||||||
|
2025 |
2024 |
|||||||||||||||||||||||
|
6/30 |
3/31 |
12/31 |
9/30 |
6/30 |
3/31 |
|||||||||||||||||||
|
|
$ |
54.58 |
$ |
55.04 |
$ |
64.70 |
$ |
77.25 |
$ |
83.96 |
$ |
90.04 |
||||||||||||
|
Three Months Ended |
Six Months Ended |
|||||||||||||||
|
($ in thousands) |
2025 |
2024 |
2025 |
2024 |
||||||||||||
|
Deferred Compensation |
||||||||||||||||
|
Operating Income (Expense) |
$ |
(1,761) |
$ |
(395) |
$ |
(765) |
$ |
(2,173) |
||||||||
|
Other, net – Mutual Fund Gain (Loss) |
1,669 |
802 |
1,299 |
3,097 |
||||||||||||
|
Total Pre-Tax |
$ |
(92) |
$ |
407 |
$ |
534 |
$ |
924 |
||||||||
|
Total After-Tax |
$ |
(69) |
$ |
305 |
$ |
401 |
$ |
693 |
||||||||
Effects of Foreign Currency Translation
The Company's foreign subsidiaries transact business and report financial results in their respective local currencies. These results are translated into
|
($ in millions) |
Three Months |
Change |
Change |
Six Months Ended |
Change |
Change |
||||||||||||||||||||||||||
|
2025 |
2024 |
2025 |
2024 |
|||||||||||||||||||||||||||||
|
|
$ |
594.7 |
$ |
556.4 |
$ |
38.3 |
$ |
(1.7) |
$ |
1,187.9 |
$ |
1,107.8 |
$ |
80.1 |
$ |
(20.2) |
||||||||||||||||
|
Gross Profit |
71.9 |
69.6 |
$ |
2.3 |
(0.2) |
147.3 |
139.8 |
$ |
7.5 |
(2.8) |
||||||||||||||||||||||
|
Operating Income |
18.0 |
18.7 |
$ |
(0.7) |
(0.2) |
46.3 |
38.8 |
$ |
7.5 |
(2.0) |
||||||||||||||||||||||
|
Pretax Income |
13.8 |
17.2 |
$ |
(3.4) |
(0.2) |
38.5 |
36.7 |
$ |
1.8 |
(2.1) |
||||||||||||||||||||||
Corporate Expenses
|
Three Months Ended |
Six Months Ended |
|||||||||||||||||||||||
|
($ in thousands) |
2025 |
2024 |
% |
2025 |
2024 |
% |
||||||||||||||||||
|
Total Corporate Expenses |
$ |
17,819 |
$ |
19,311 |
(8) |
% |
$ |
31,987 |
$ |
37,872 |
(16) |
% |
||||||||||||
|
Less: |
||||||||||||||||||||||||
|
Deferred Compensation (Income) Expense |
$ |
1,761 |
$ |
395 |
346 |
% |
$ |
765 |
$ |
2,173 |
(65) |
% |
||||||||||||
|
Environmental Remediation |
$ |
722 |
$ |
240 |
201 |
% |
$ |
814 |
$ |
1,774 |
(54) |
% |
||||||||||||
|
Adjusted Corporate Expenses |
$ |
15,336 |
$ |
18,676 |
(18) |
% |
$ |
30,408 |
$ |
33,925 |
(10) |
% |
||||||||||||
Adjusted Corporate expenses decreased
|
Table V |
||||||||
|
|
||||||||
|
Consolidated Balance Sheets |
||||||||
|
|
||||||||
|
|
|
|||||||
|
ASSETS |
||||||||
|
Current Assets |
$ |
906,106 |
$ |
810,429 |
||||
|
Property, |
1,212,928 |
1,198,454 |
||||||
|
Other Assets |
297,096 |
295,765 |
||||||
|
Total Assets |
$ |
2,416,130 |
$ |
2,304,648 |
||||
|
LIABILITIES AND STOCKHOLDERS' EQUITY |
||||||||
|
Current Liabilities |
$ |
673,273 |
$ |
669,034 |
||||
|
Deferred Income Taxes |
10,385 |
9,612 |
||||||
|
Long-term Debt |
383,239 |
332,632 |
||||||
|
Other Non-current Liabilities |
107,520 |
123,436 |
||||||
|
Total Stepan Company Stockholders' Equity |
1,241,713 |
1,169,934 |
||||||
|
Total Liabilities and Stockholders' Equity |
$ |
2,416,130 |
$ |
2,304,648 |
||||
Selected Balance Sheet Information
The Company's total debt decreased by
|
($ in millions) |
|
|
|
|||||||||
|
Net Debt |
||||||||||||
|
Total Debt |
$ |
658.0 |
$ |
659.3 |
$ |
625.4 |
||||||
|
Cash |
88.9 |
107.5 |
99.7 |
|||||||||
|
Net Debt |
$ |
569.1 |
$ |
551.8 |
$ |
525.7 |
||||||
|
Equity |
1,241.7 |
1,200.5 |
1,169.9 |
|||||||||
|
Net Debt + Equity |
$ |
1,810.8 |
$ |
1,752.3 |
$ |
1,695.6 |
||||||
|
Net Debt / (Net Debt + Equity) |
31 |
% |
31 |
% |
31 |
% |
||||||
The major working capital components were:
|
($ in millions) |
|
|
|
|||||||||
|
Net Receivables |
$ |
442.2 |
$ |
436.5 |
$ |
388.0 |
||||||
|
Inventories |
329.5 |
309.3 |
288.7 |
|||||||||
|
Accounts Payable |
(281.8) |
(298.1) |
(258.8) |
|||||||||
|
$ |
489.9 |
$ |
447.7 |
$ |
417.9 |
|||||||
|
Table VI |
||||||||||||||||||||
|
Reconciliations of Non-GAAP EBITDA and Adjusted EBITDA |
||||||||||||||||||||
|
Management uses the non-GAAP EBITDA and adjusted EBITDA metrics to evaluate the Company's operating performance. Management excludes the items listed in the table below because they are non-operational items. Refer to the Income Statement on Table I for a bridge between Operating Income and Net Income. |
||||||||||||||||||||
|
Three Months Ended |
||||||||||||||||||||
|
($ in millions) |
Surfactants |
Polymers |
Specialty |
Unallocated |
Consolidated |
|||||||||||||||
|
Operating Income |
$ |
13.4 |
$ |
17.2 |
$ |
5.2 |
$ |
(17.8) |
$ |
18.0 |
||||||||||
|
Depreciation and Amortization |
$ |
21.1 |
$ |
8.4 |
$ |
1.5 |
$ |
0.3 |
$ |
31.3 |
||||||||||
|
Other, Net Income |
$ |
- |
$ |
- |
$ |
- |
$ |
1.3 |
$ |
1.3 |
||||||||||
|
EBITDA |
$ |
50.6 |
||||||||||||||||||
|
Deferred Compensation |
$ |
- |
$ |
- |
$ |
- |
$ |
0.1 |
$ |
0.1 |
||||||||||
|
Environmental Remediation |
$ |
- |
$ |
- |
$ |
- |
$ |
0.7 |
$ |
0.7 |
||||||||||
|
Adjusted EBITDA |
$ |
34.5 |
$ |
25.6 |
$ |
6.7 |
$ |
(15.4) |
$ |
51.4 |
||||||||||
|
Three Months Ended |
||||||||||||||||||||
|
($ in millions) |
Surfactants |
Polymers |
Specialty |
Unallocated |
Consolidated |
|||||||||||||||
|
Operating Income |
$ |
17.1 |
$ |
13.6 |
$ |
7.3 |
$ |
(19.3) |
$ |
18.7 |
||||||||||
|
Depreciation and Amortization |
$ |
17.9 |
$ |
8.2 |
$ |
1.5 |
$ |
0.4 |
$ |
28.0 |
||||||||||
|
Other, Net Income |
$ |
- |
$ |
- |
$ |
- |
$ |
1.2 |
$ |
1.2 |
||||||||||
|
EBITDA |
$ |
47.9 |
||||||||||||||||||
|
Deferred Compensation |
$ |
- |
$ |
- |
$ |
- |
$ |
(0.4) |
$ |
(0.4) |
||||||||||
|
Environmental Remediation |
$ |
- |
$ |
- |
$ |
- |
$ |
0.2 |
$ |
0.2 |
||||||||||
|
Adjusted EBITDA |
$ |
35.0 |
$ |
21.8 |
$ |
8.8 |
$ |
(17.9) |
$ |
47.7 |
||||||||||
|
Six Months Ended |
||||||||||||||||||||
|
($ in millions) |
Surfactants |
Polymers |
Specialty |
Unallocated |
Consolidated |
|||||||||||||||
|
Operating Income |
$ |
42.3 |
$ |
25.2 |
$ |
10.8 |
$ |
(32.0) |
$ |
46.3 |
||||||||||
|
Depreciation and Amortization |
$ |
40.6 |
$ |
16.4 |
$ |
2.9 |
$ |
0.6 |
$ |
60.5 |
||||||||||
|
Other, Net Income |
$ |
- |
$ |
- |
$ |
- |
$ |
1.8 |
$ |
1.8 |
||||||||||
|
EBITDA |
$ |
108.6 |
||||||||||||||||||
|
Deferred Compensation |
$ |
- |
$ |
- |
$ |
- |
$ |
(0.5) |
$ |
(0.5) |
||||||||||
|
Environmental Remediation |
$ |
- |
$ |
- |
$ |
- |
$ |
0.8 |
$ |
0.8 |
||||||||||
|
Adjusted EBITDA |
$ |
82.9 |
$ |
41.6 |
$ |
13.7 |
$ |
(29.3) |
$ |
108.9 |
||||||||||
|
Six Months Ended |
||||||||||||||||||||
|
($ in millions) |
Surfactants |
Polymers |
Specialty |
Unallocated |
Consolidated |
|||||||||||||||
|
Operating Income |
$ |
43.1 |
$ |
22.0 |
$ |
11.6 |
$ |
(37.9) |
$ |
38.8 |
||||||||||
|
Depreciation and Amortization |
$ |
35.5 |
$ |
16.2 |
$ |
3.0 |
$ |
0.9 |
$ |
55.6 |
||||||||||
|
Other, Net Income |
$ |
- |
$ |
- |
$ |
- |
$ |
3.6 |
$ |
3.6 |
||||||||||
|
EBITDA |
$ |
98.0 |
||||||||||||||||||
|
Deferred Compensation |
$ |
- |
$ |
- |
$ |
- |
$ |
(0.9) |
$ |
(0.9) |
||||||||||
|
Environmental Remediation |
$ |
- |
$ |
- |
$ |
- |
$ |
1.8 |
$ |
1.8 |
||||||||||
|
Adjusted EBITDA |
$ |
78.6 |
$ |
38.2 |
$ |
14.6 |
$ |
(32.5) |
$ |
98.9 |
||||||||||
View original content to download multimedia:https://www.prnewswire.com/news-releases/stepan-reports-second-quarter-2025-results-302517180.html
SOURCE
Samuel S. Hinrichsen, 847-446-7500